Literature DB >> 8549220

Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis.

G J Fahy1, T Marwick, C J McCreery, P J Quigley, B J Maurer.   

Abstract

STUDY
OBJECTIVE: To determine the prevalence of left ventricular diastolic dysfunction in patients with biopsy specimen-proved pulmonary sarcoidosis without clinical evidence of cardiac disease.
DESIGN: A cross-sectional study.
SETTING: A large tertiary care university teaching hospital. PATIENTS AND CONTROL
SUBJECTS: Fifty consecutive subjects had biopsy specimen-proved pulmonary sarcoidosis without suspected cardiac involvement. Those with other conditions known to affect diastolic function were excluded. The control group comprised 30 healthy hospital workers.
INTERVENTIONS: Clinical examination, 12-lead ECG, and combined echocardiographic/phonocardiographic examination. MEASUREMENTS: Indexes of left ventricular diastolic function, including isovolumic relaxation time, peak velocity of early (E) and late (A) ventricular filling, deceleration rate of early diastolic flow, and the sum of the time velocity integrals of E and A were obtained in each patient and control subject. Systolic function was determined using a modification of Simpson's rule.
RESULTS: Diastolic dysfunction was present in 7 (14%) patients, 6 of whom had normal systolic function and normal two-dimensional echocardiographic examination. Those with diastolic dysfunction had a longer duration of illness (15 +/- 7 vs 6 +/- 5 years; p = 0.0004), were significantly older (52 +/- 11 vs 38 +/- 9 years; p = 0.0009), and had higher systolic BP (130 +/- 13 vs 117 +/- 12 mm Hg; p = 0.01) than the sarcoid patients with normal diastolic function.
CONCLUSIONS: These results demonstrate a significant prevalence of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. The cause of this abnormality may be a subclinical sarcoid cardiomyopathy.

Entities:  

Mesh:

Year:  1996        PMID: 8549220     DOI: 10.1378/chest.109.1.62

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  22 in total

1.  Cardiac sarcoidosis with a rare initial manifestation: sustained monomorphic ventricular tachycardia.

Authors:  Gautamy Chitiki Dhadham; Nishant Gupta; Rupen Parikh; Mahesh Bikkina
Journal:  Tex Heart Inst J       Date:  2011

Review 2.  Role of Imaging in Evaluating Infiltrative Heart Disease.

Authors:  Sanjay Divakaran; Avinainder Singh; Bradley Collins; Tomas Vita; Rodney H Falk; Marcelo F Di Carli; Ron Blankstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

3.  Early Detection of Bi-ventricular and Atrial Mechanical Dysfunction Using Two-Dimensional Speckle Tracking Echocardiography in Patients with Sarcoidosis.

Authors:  Kursat Tigen; Murat Sunbul; Tansu Karaahmet; Onur Tasar; Cihan Dundar; Murat Yalcinsoy; Mumtaz Takir; Esen Akkaya
Journal:  Lung       Date:  2015-05-20       Impact factor: 2.584

4.  A Diagnostic and Therapeutic Approach to Arrhythmias in Cardiac Sarcoidosis.

Authors:  Brian A Houston; Carolyn Park; Monica Mukherjee
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-03

Review 5.  Sarcoid heart disease.

Authors:  Simon W Dubrey; Alex Bell; Tarun K Mittal
Journal:  Postgrad Med J       Date:  2007-10       Impact factor: 2.401

6.  Cardiac sarcoidosis: diagnosis and management.

Authors:  Michelle Bussinguer; Alfred Danielian; Om P Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

Review 7.  Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.

Authors:  Joseph P Lynch; Jennifer Hwang; Jason Bradfield; Michael Fishbein; Kalyanam Shivkumar; Roderick Tung
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

Review 8.  Updates on the Role of Imaging in Cardiac Sarcoidosis.

Authors:  Yan Yatsynovich; Damian Valencia; Mikhail Petrov; Juan David Linares; Mufti M Rahman; Nathaniel Dittoe
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-07

Review 9.  Idiopathic giant cell myocarditis and cardiac sarcoidosis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

10.  Myocardial performance index for detection of subclinical abnormalities in patients with sarcoidosis.

Authors:  Mehmet Gungor Kaya; Zuhal Simsek; Bahadir Sarli; Hakan Buyukoglan
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.